28 results on '"Drummer, Heidi E."'
Search Results
2. Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial
3. COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants
4. B-cell characteristics define HCV reinfection outcome
5. Accuracy and precision of a point of care SARS-CoV-2 antigen rapid diagnostic test assessed in an Australian cohort
6. An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development
7. Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis.
8. Injecting drug use and hepatitis C virus infection independently increase biomarkers of inflammatory disease risk which are incompletely restored by curative direct-acting antiviral therapy
9. Bridging the gap: A new tool to down select HCV vaccine candidates.
10. Dimeric immunoglobulin A as a novel diagnostic marker of measles infection
11. Joint statement in support of hepatitis C human challenge studies
12. Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after with mRNA but not adenovirus priming
13. Serological assays to measure dimeric IgA antibodies in SARS‐CoV‐2 infections
14. Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core
15. Joint statement in support of hepatitis C human challenge studies
16. COVID-19 adenoviral vector vaccination elicits a robust memory B cell response with the capacity to recognize Omicron BA.2 and BA.5 variants
17. Validation of a novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study
18. B Cell Signatures and Antibody Imprinting Define HCV Reinfection Outcome
19. The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2
20. Enhanced stability of the SARS CoV-2 spike glycoprotein trimer following modification of an alanine cavity in the protein core
21. Validation of novel point‐of‐care test for alanine aminotransferase measurement: A pilot cohort study
22. Double-dose mRNA vaccination to SARS-CoV-2 progressively increases recognition of variants-of-concern by Spike RBD-specific memory B cells
23. Point-of-Care Diagnostics for Diagnosis of Active Syphilis Infection: Needs, Challenges and the Way Forward
24. A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
25. Virus-Like Particles Containing the E2 Core Domain of Hepatitis C Virus Generate Broadly Neutralizing Antibodies in Guinea Pigs
26. The second COVID‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA.2.
27. A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
28. Dimeric immunoglobulin A as a novel diagnostic marker of measles infection.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.